España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Catalyst Pharmaceuticals
CPRX
NASDAQ
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$16.90
-0.09
-0.53%
At Close: -
$16.90
0
0.00%
After Hours: 4:57 PM EDT
15 minutes delayed
Get Report
Comment
Catalyst Pharmaceuticals (CPRX) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Catalyst Pharmaceuticals (NASDAQ:CPRX) Stock
Catalyst Pharmaceuticals Stock (NASDAQ: CPRX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, June 12, 2024
Insider Transaction: Jeffrey Del Carmen Sells $121K Worth Of Catalyst Pharmaceuticals Shares
Benzinga Insights
Thursday, June 06, 2024
Catalyst Pharmaceuticals Board Member Sold $86K In Company Stock
Benzinga Insights
Insider Transaction: Richard J Daly Sells $276K Worth Of Catalyst Pharmaceuticals Shares
Benzinga Insights
Monday, June 03, 2024
A Closer Look at 7 Analyst Recommendations For Catalyst Pharmaceuticals
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Catalys...
Benzinga Newsdesk
Thursday, May 30, 2024
Catalyst Pharmaceuticals Announces FDA Approv...
Benzinga Newsdesk
Friday, May 10, 2024
Decoding 8 Analyst Evaluations For Catalyst Pharmaceuticals
Benzinga Insights
HC Wainwright & Co. Maintains Buy on Catalyst...
Benzinga Newsdesk
Wednesday, May 08, 2024
Catalyst Pharmaceuticals Reaffirms FY24 Total...
Benzinga Newsdesk
Catalyst Pharmaceuticals Q1 Adj $0.38 Beats $...
Benzinga Newsdesk
Wednesday, March 27, 2024
Decoding 7 Analyst Evaluations For Catalyst Pharmaceuticals
Benzinga Insights
Oppenheimer Reiterates Outperform on Catalyst...
Benzinga Newsdesk
Friday, March 22, 2024
Cantor Fitzgerald Reiterates Overweight on Ca...
Benzinga Newsdesk
Thursday, March 14, 2024
Cantor Fitzgerald Reiterates Overweight on Ca...
Benzinga Newsdesk
Citigroup Initiates Coverage On Catalyst Phar...
Benzinga Newsdesk
Wednesday, March 13, 2024
Catalyst Pharmaceuticals Announces AGAMREE No...
Benzinga Newsdesk
Thursday, March 07, 2024
Assessing Catalyst Pharmaceuticals: Insights From 4 Financial Analysts
Benzinga Insights
B of A Securities Initiates Coverage On Catal...
Benzinga Newsdesk
Friday, March 01, 2024
Cantor Fitzgerald Maintains Overweight on Cat...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Catalys...
Benzinga Newsdesk
Thursday, February 29, 2024
Top 3 Health Care Stocks You May Want To Dump In Q1
Avi Kapoor
Catalyst Pharmaceuticals Expects 2024 Total R...
Benzinga Newsdesk
Catalyst Pharmaceuticals Q4 Adj. EPS $0.53 Be...
Benzinga Newsdesk
Wednesday, February 28, 2024
Earnings Scheduled For February 28, 2024
Benzinga Insights
Tuesday, February 27, 2024
Earnings Preview For Catalyst Pharmaceuticals
Benzinga Insights
Catalyst Pharmaceuticals To Present At MDA Cl...
Benzinga Newsdesk
Wednesday, February 21, 2024
Catalyst Pharmaceuticals Announces Publicatio...
Benzinga Newsdesk
Monday, January 22, 2024
Jim Cramer Likes This Bank 'Very, Very Much,' Says Stock Is Up 7% Over Past 6 Months
Avi Kapoor
Friday, January 05, 2024
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
Catalyst Pharmaceuticals shares are trading l...
Benzinga Newsdesk
Why Catalyst Pharmaceuticals Stock Is Trading Lower
Henry Khederian
Catalyst Pharmaceuticals, Inc. Announces Pric...
Benzinga Newsdesk
Franklin Covey Shares Fall After Q1 Results, Joins Theravance Biopharma, Voyager Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Avi Kapoor
Thursday, January 04, 2024
Catalyst Pharmaceuticals Begins Public Offeri...
Benzinga Newsdesk
Thursday, December 21, 2023
Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
Catalyst Pharmaceuticals shares are trading h...
Benzinga Newsdesk
Oppenheimer Initiates Coverage On Catalyst Ph...
Benzinga Newsdesk
Wednesday, December 20, 2023
Insider Unloading: Molly Harper Sells $201K Worth Of Catalyst Pharmaceuticals Shares
Benzinga Insights
Monday, December 18, 2023
Catalyst Pharmaceuticals Announces FIRDAPSE N...
Benzinga Newsdesk
Friday, December 15, 2023
Insider Transaction: David S Tierney Sells $666K Worth Of Catalyst Pharmaceuticals Shares
Benzinga Insights
Monday, December 04, 2023
Catalyst Pharmaceuticals Appoints Michael Kal...
Benzinga Newsdesk
Wednesday, November 08, 2023
Recap: Catalyst Pharmaceuticals Q3 Earnings
Benzinga Insights
Catalyst Pharmaceuticals Raises FY23 Revenue ...
Benzinga Newsdesk
Catalyst Pharmaceuticals Q3 EPS $0.49 Beats $...
Benzinga Newsdesk
Earnings Scheduled For November 8, 2023
Benzinga Insights
Thursday, November 02, 2023
Catalyst Pharmaceuticals Receives Two New U.S...
Benzinga Newsdesk
Thursday, October 26, 2023
Catalyst Pharmaceuticals Shares Resume Trade
Happy Mohamed
Catalyst Pharmaceuticals, Inc. Shares To Resu...
Benzinga Newsdesk
Watching Catalyst Pharmaceuticals; Traders Ci...
Benzinga Newsdesk
Catalyst Pharmaceuticals Shares Halted, News ...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch